Up a level |
Banerjee, Susana ORCID: 0000-0002-8840-7934, Michalarea, Vasiliki ORCID: 0000-0002-3102-3534, Ang, Joo Ern ORCID: 0000-0003-2103-996X, Ingles Garces, Alvaro ORCID: 0000-0002-0073-4237, Biondo, Andrea ORCID: 0000-0003-0599-254X, Funingana, Ionut-Gabriel ORCID: 0000-0002-1197-2652, Little, Martin ORCID: 0000-0003-2592-1570, Ruddle, Ruth ORCID: 0000-0003-0025-8872, Raynaud, Florence ORCID: 0000-0003-0957-6279, Riisnaes, Ruth ORCID: 0000-0002-8924-302X et al (show 19 more authors)
(2022)
A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research, 28 (21).
pp. 4634-4641.
Love, Sharon B, Cafferty, Fay, Snowdon, Claire, Carty, Karen, Savage, Joshua, Pallmann, Philip, McParland, Lucy, Brown, Louise, Masters, Lindsey, Schiavone, Francesca et al (show 26 more authors)
(2022)
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units.
Trials, 23 (1).
p. 757.
Patel, Emma, Tsang, Yat, Baker, Angela, Callender, Jenny ORCID: 0000-0003-2230-0613, Hafeez, Shaista, Hall, Emma, Hansen, Vibeke Nordmark, Lewis, Rebecca, McNair, Helen, Miles, Elizabeth et al (show 1 more authors)
(2019)
Quality assuring "Plan of the day" selection in a multicentre adaptive bladder trial: Implementation of a pre-accrual IGRT guidance and assessment module.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 19.
pp. 27-32.